Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 8, 2023. (Total: 223870Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Colitis and CCR5[original query]
The CC chemokine receptor 5 delta32 mutation is not associated with inflammatory bowel disease (IBD) in NE England.
Genes and immunity 2001 Apr 2 (2): 114-6.
Craggs A, Welfare M, Donaldson P T, Mansfield J
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
Human genetics 2001 Mar 108 (3): 190-3.
Rector A, Vermeire S, Thoelen I, Keyaerts E, Struyf F, Vlietinck R, Rutgeerts P, Van Ranst
Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease.
Clinical immunology (Orlando, Fla.) 2001 Jan 98 (1): 18-22.
Martin K, Heinzlmann M, Borchers R, Mack M, Loeschke K, Folwaczny
CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
Genes and immunity 2004 Sep 5 (6): 444-50.
Eri R, Jonsson J R, Pandeya N, Purdie D M, Clouston A D, Martin N, Duffy D, Powell E E, Fawcett J, Florin T H J, Radford-Smith G
CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis.
Inflammatory bowel diseases 2006 Apr 12 (4): 272-7.
Henckaerts Liesbet, Fevery Johan, Van Steenbergen Werner, Verslype Chris, Yap Paul, Nevens Frederik, Roskams Tania, Libbrecht Louis, Rutgeerts Paul, Vermeire Séveri
Association of chemokine and chemokine receptor polymorphisms with activity degree of IBD in Tunisian patients.
Archives de l'Institut Pasteur de Tunis 2013 3 88 (1-4): 47-58.
Gorgi Y, Ben Aleya W, Sfar I, Aounallah-Skhiri H, Mouelhi L, Jendoubi-Ayed S, Makhlouf M, Ben Rhomdhane T, Matri S, Filali A, Aouadi H, Najjar T, Ben Abdallah T, Ayed
TOP